Crying in O.Y.
Host Zac returns to the "Crying in Olive Young" studio to dissect the success of Torriden, a brand that has mastered the middle ground between "Clean Beauty" and "Dermacosmetics." With the Dive-In Low Molecular Hyaluronic Acid Serum reaching 11 million units sold as of 2025, Torriden isn't just a trend—it's a category leader. We explore the "5-D Complex" technology that makes their HA serum a global bestseller at Sephora and Boots, and why it consistently tops the Olive Young charts. The Business Sidebar: We address the rumors surrounding LG Household & Health Care (LG H&H) and their interest in the indie market. What does CEO Lee Sun-Joo’s "Agile Adaptation" strategy mean for the future of K-Beauty? Plus, we provide an essential update on Dr. Althea’s recent press release regarding their 2026 expansion and internal sale discussions. Key Highlights: * Torriden’s "Your Skin is Our Planet" ethos. * The math behind a 100-billion-won brand. * Hyaluronic Acid: Molecular weights explained. * LG H&H’s shift away from legacy brands toward indie prospects. * Dr. Althea’s 2026 recruitment and growth update. Connect with us:IG: @CryingInOliveYoungKorean Language K-Beauty Updates: @Goojeon
7 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Crying in O.Y.!